Team Leader : Charles Theillet
Institut de Recherche en
Cancérologie de Montpellier
CRLC Val d’Aurelle-Paul Lamarque
34298 Montpellier cedex 5
|
|
Tél. : 33 (0)4 67 61 37 66
Fax : 33 (0)4 67 61 30 41
theillet@valdorel.fnclcc.fr |
Research topics
Our lab “Tumor Identity and Plasticity” is located on the campus of the Cancer Center of Montpellier, which is the largest Cancer Hospital in Languedoc-Roussillon.
Research developed is related to our close proximity to the clinical departments and address molecular and cellular biology of cancer. Our topics cover both basic and translational aspects. Our final aim is to improve cancer diagnosis in order to reinforce patient management and identify novel therapeutical targets. Our research is in line with the main clinical orientations of the Cancer Center, i.e. focused on solid cancer.
more informations ...
|
|
Main Publications
Charles Theillet. What do we learn from HER2-positive breast cancer genomic profiles? Breast Cancer Research 2010, 12:107 (1 June 2010)
Tuduri S, Crabbe L, Tourrière H, Coquelle A, Pasero P. Does interference between replication and transcription contribute to genomic instability in cancer cells? Cell Cycle. 2010 May 17;9(10). [Epub ahead of print]PMID: 20495385
Herfs M, Hubert P, Suarez-Carmona M, Reschner A, Saussez S, Berx G, Savagner P, Boniver J, Delvenne P. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. Am J Pathol. 2010 Apr;176(4):1941-9. Epub 2010 Feb 11.PMID: 20150431
Docquier A, Harmand PO, Fritsch S, Chanrion M, Darbon JM, Cavaillès V. The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes. Clin Cancer Res. 2010 May 18. [Epub ahead of print]PMID: 20410059
more informations ...
|
